ebm.bmj

Pyramids are guides not rules: the evolution of the evidence pyramid

Correspondence to: Dr Terrence Shaneyfelt, Department of Veterans Affairs and UAB Department of Medicine, 700 S 19th Street, Birmingham, Alabama 35233, USA; terry.shaneyfelt{at}va.gov If you wish to ...
ebm.bmj

Catalogue of bias: attrition bias

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj

Should COVID-19 vaccination be mandatory?

Correspondence to Dr Juan Victor Ariel Franco, Research Department, Instituto Universitario del Hospital Italiano de Buenos Aires, 1199 Buenos Aires, Argentina; juanfranco{at}bmj.com ...
ebm.bmj

Inclusion and exclusion criteria and the problem of describing homogeneity of study populations in clinical trials

Correspondence to Dr Franz Porzsolt, Health Care Research at the Dept General and Visceral Surgery, University Hospital Ulm, Ulm 89071, Germany; f.porzsolt{at}gmx.de The description of results in ...
ebm.bmj

A primer to planetary health in evidence-based medicine and clinical decision-making

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj

Responsible dissemination of health and medical research: some guidance points

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj

Mixed kinds of evidence: synthesis designs and critical appraisal for systematic mixed studies reviews including qualitative, quantitative and mixed methods studies

Correspondence to: Professor Pierre Pluye Department of Family Medicine, McGill University, Montreal, Quebec, Canada H3S 1Z1; pierre.pluye{at}mcgill.ca The present letter is to thank Drs Shaw, Larkin ...
ebm.bmj

Setting new research in the context of previous research: some options

Correspondence to Professor Paul Glasziou, Instiute for Evidence Based Heathcare, Bond University, Robina, Queensland, Australia; pglaszio{at}bond.edu.au Without this visual information in figure 1, ...
ebm.bmj

1 False positive risk: a solution to the problem of P-values

Objectives It is a truth universally acknowledged that some areas of science suffer from a surfeit of false positives. It is still widely beiieved that the p-value is the probability that your results ...
ebm.bmj

Adverse events of inhaled corticosteroids in adult patients with asthma or chronic obstructive pulmonary disease: pairwise, network and dose–response meta-analyses

Objectives This study aimed to evaluate the associations between inhaled corticosteroids (ICSs) and adverse events (AEs) in adults with asthma or chronic obstructive pulmonary disease (COPD) and to ...
ebm.bmj

157 Medical science liaisons: pharma’s best kept secret

Medical Science Liaisons (MSLs) are individuals with advanced scientific training (typically a PhD, PharmD, or MD) who are employed by pharmaceutical and medical device companies to forge ...
ebm.bmj

The limits of shared decision making

Correspondence to Professor Glyn Elwyn, The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Hanover, New Hampshire 03755, USA; glynelwyn{at}gmail.com Nevertheless we ...